Relapses of MALT lymphoma may be late and lifelong observation may be required. [9] Investigations General assessment: FBC, renal function tests, electrolytes, LFTs. Phenotyping of circulating lymphocytes, bone marrow lymphocytes or biopsy specimens. Imaging studies for disease staging:
Barium contrast studies of the upper and lower gastrointestinal tract. CT scan and MRI scan.
Endoscopy. Bone marrow aspiration.
Management
Management is different for gastric and non-gastric MALT lymphomas.
Treatment with a proton pump inhibitor (PPI) and antibiotics to eradicate H. pylori is the main treatment for most gastric MALT lymphomas, which are often low-grade and remain localised for several years. Treatment with chemotherapy, surgery or radiotherapy has not been demonstrated to be superior to antibiotic treatment. Treatments for non-gastric MALT lymphomas include radiotherapy, chemotherapy, monoclonal antibodies and surgery. Rituximab alone or in combination with chemotherapy is reported to provide high response rates and has been advocated for those with disseminated or recurrent disease. [10] Surgery has only a limited role in treatment. Surgery for non-gastrointestinal MALT lymphoma is usually restricted to excisional biopsies. Partial or total gastrectomy is associated with considerable morbidity and is rarely necessary.
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